Neoadjuvant chemotherapy with epirubicin-vinorelbine and G-CSF in locoregionally advanced breast cancer: Our experience

被引:0
|
作者
Savarino, A. [1 ]
Fabiano, E. [1 ]
Maniaci, V [1 ]
Puliafito, I [1 ]
Sauta, M. G. [1 ]
Bene, A. [1 ]
机构
[1] Univ Messina, Human Pathol Dept, Med Oncol & Innovat Therapies Unit, I-98100 Messina, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:43 / 43
页数:1
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy with Vinorelbine and Epirubicin in locally advanced breast cancer (LABC).
    Puerto, VL
    Cardenas, J
    Lara, F
    Goana, R
    Silva, A
    Barroso, N
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 299 - 299
  • [2] Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer
    Vici, P
    Foggi, P
    Colucci, G
    Capomolla, E
    Brandi, M
    Giotta, F
    Gebbia, N
    Di Lauro, L
    Valerio, MR
    Paoletti, G
    Belli, F
    Pizza, C
    Giannarelli, D
    Lopez, M
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1309 - 1314
  • [3] Comparison of epirubicin and vinorelbine with cyclophosphamide, epirubicin, and fluorouracil as neoadjuvant chemotherapy for operable breast cancer
    Han, S.
    Kwak, K.
    Kim, J.
    Kim, J.
    Park, K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 122 - 122
  • [4] Combination of vinorelbine, epirubicin, and cyclophosphamide as Neoadjuvant chemotherapy for locally advanced breast cancer - Phase II study
    Braud, AC
    Levy, E
    Feuilhade, F
    Otmezguine, Y
    Calitchi, E
    Kirova, Y
    Le Bourgeois, JP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (03): : 303 - 307
  • [5] Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer
    Nisticò, C
    De Matteis, A
    Ross, E
    Carnino, F
    Valenza, R
    Agostara, B
    Bria, E
    Farris, A
    Cremonesi, M
    D'Ottavio, AM
    Vaccaro, A
    Garufi, C
    Giunta, S
    Botti, C
    Perrone, F
    Terzoli, E
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1343 - 1348
  • [6] Treatment of advanced refractory breast cancer with docetaxel alternating with epirubicin and cyclophosphamide (EC)+G-CSF
    Valencak, J
    Kornek, GV
    Haider, K
    Raderer, M
    Kwasny, W
    Bareck, E
    Weinlander, G
    Depisch, D
    Kovats, E
    Scheithauer, W
    ANNALS OF ONCOLOGY, 1998, 9 : 180 - 180
  • [7] Treatment of advanced refractory breast cancer with docetaxel alternating with epirubicin and cyclophosphamide (EC)+G-CSF
    Weinländer, G
    Kornek, GV
    Haider, K
    Raderer, M
    Valencak, J
    Kwasny, W
    Bareck, E
    Depisch, D
    Kovats, E
    Scheithauer, W
    BRITISH JOURNAL OF CANCER, 1998, 78 : 10 - 10
  • [8] Vinorelbine and farmorubicin as neoadjuvant chemotherapy in locally advanced breast cancer
    Gaafar, RM
    Hamza, MR
    ElZawahry, H
    Khaled, H
    Helal, A
    Eissa, S
    AbdelBaki, H
    ElKalaawy, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S329 - S329
  • [9] NEOADJUVANT CHEMOTHERAPY OF BREAST CANCER: OUR EXPERIENCE
    Latiano, T. P.
    D'Addetta, C.
    Lombardi, L.
    Cilenti, G.
    Piano, A.
    Murgo, R.
    Di Candia, L.
    Maiello, E.
    CANCER TREATMENT REVIEWS, 2010, 36 : S100 - S101
  • [10] Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer
    Makatsoris, Thomas
    Papakostas, Pavlos
    Kalofonos, Haralahos P.
    Xanthakis, Loannis
    Tsavdaridis, Dimitrios
    Aravantinos, Gerasimos
    Gogas, Helen
    Klouvas, George
    Kosmidis, Paris
    Pectasides, Dimitrios
    Fountzilas, George
    MEDICAL ONCOLOGY, 2007, 24 (03) : 301 - 307